Ads
related to: cll leukemia treatment options- FDA-Approved Treatment
Read About A Treatment For CLL
And Access Other Support Resources.
- Important Safety Info
View Clinical Data For A
CLL Therapy.
- How To Order Brochure
Learn How To Order A Treatment
For Chronic Lymphocytic Leukemia.
- BTK Inhibitor Info
BTK Signaling Plays A Role In
Your Treatment. Learn More.
- Request A Representative
Fill Out A Brief Form To Request
A Representative.
- Clinical Trial Data
See Efficacy Info On FDA-Approved
CLL Treatment.
- FDA-Approved Treatment
Search results
Results From The WOW.Com Content Network
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. [8] [9] In CLL, the bone marrow makes too many lymphocytes, which are a type of white blood cell. [8] [9] In patients with CLL, B cell lymphocytes can begin to collect in their blood, spleen, lymph nodes, and bone marrow.
In the EU, venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukemia (CLL) in the presence of 17p deletion or TP53 mutation in adults who are unsuitable for or have failed a B cell receptor pathway inhibitor and for the treatment of CLL in the absence of 17p deletion or TP53 mutation in adults who have failed both ...
Treatment can occasionally consist of "watchful waiting" (e.g., in CLL) or symptomatic treatment (e.g., blood transfusions in MDS). The more aggressive forms of disease require treatment with chemotherapy, radiotherapy, immunotherapy and—in some cases—a bone marrow transplant.
Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. [8] In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. [8] It is given by injection into a vein. [8]
The 83-year-old was diagnosed with chronic lymphocytic leukemia, a type of blood cancer that begins in the bone marrow, in 2005. She underwent treatment, including chemotherapy, and went into ...
chronic lymphocytic leukemia: Ceritinib [1] Novartis Pharmaceuticals: ALK-positive metastatic non-small cell lung cancer: Idelalisib [1] Gilead Sciences: relapsed chronic lymphocytic leukemia: Ibrutinib [1] Pharmacyclics: chronic lymphocytic leukemia (with 17p deletion Eltrombopag [1] Novartis Pharmaceuticals: aplastic anemia: Pembrolizumab [1 ...
Ads
related to: cll leukemia treatment options